Concepts (55)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biliary Atresia | 2 | 2023 | 206 | 1.200 |
Why?
|
| Hypertension, Portal | 2 | 2022 | 80 | 0.840 |
Why?
|
| Cholangitis | 1 | 2023 | 40 | 0.790 |
Why?
|
| Hepatitis | 4 | 2023 | 58 | 0.750 |
Why?
|
| Adenovirus Infections, Human | 3 | 2023 | 57 | 0.580 |
Why?
|
| Adenoviridae Infections | 3 | 2023 | 69 | 0.570 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2017 | 73 | 0.520 |
Why?
|
| Colitis, Ulcerative | 1 | 2017 | 218 | 0.450 |
Why?
|
| Crohn Disease | 1 | 2017 | 291 | 0.440 |
Why?
|
| Phenotype | 1 | 2017 | 4569 | 0.270 |
Why?
|
| Liver Cirrhosis | 2 | 2025 | 898 | 0.260 |
Why?
|
| Liver Transplantation | 3 | 2025 | 1103 | 0.250 |
Why?
|
| Adenoviruses, Human | 2 | 2023 | 98 | 0.240 |
Why?
|
| Hypopituitarism | 1 | 2025 | 18 | 0.230 |
Why?
|
| Growth Hormone | 1 | 2025 | 150 | 0.220 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2025 | 74 | 0.220 |
Why?
|
| Human Growth Hormone | 1 | 2025 | 80 | 0.220 |
Why?
|
| Child | 10 | 2025 | 25886 | 0.210 |
Why?
|
| Prognosis | 3 | 2025 | 5040 | 0.200 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2023 | 50 | 0.200 |
Why?
|
| Fatty Liver | 1 | 2025 | 210 | 0.200 |
Why?
|
| Varicose Veins | 1 | 2022 | 31 | 0.190 |
Why?
|
| Hepatorenal Syndrome | 1 | 2022 | 28 | 0.190 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2022 | 77 | 0.190 |
Why?
|
| Dependovirus | 1 | 2023 | 153 | 0.180 |
Why?
|
| Liver Failure, Acute | 1 | 2023 | 94 | 0.180 |
Why?
|
| Coinfection | 1 | 2023 | 184 | 0.170 |
Why?
|
| Portoenterostomy, Hepatic | 1 | 2021 | 60 | 0.170 |
Why?
|
| Gastroenteritis | 1 | 2023 | 366 | 0.160 |
Why?
|
| Retrospective Studies | 4 | 2023 | 17490 | 0.160 |
Why?
|
| Acute Disease | 4 | 2023 | 1187 | 0.150 |
Why?
|
| Liver | 2 | 2023 | 1852 | 0.150 |
Why?
|
| Infant | 3 | 2023 | 13257 | 0.140 |
Why?
|
| Treatment Outcome | 2 | 2023 | 13067 | 0.120 |
Why?
|
| Alabama | 2 | 2022 | 47 | 0.100 |
Why?
|
| Humans | 10 | 2025 | 133185 | 0.090 |
Why?
|
| Disease Progression | 1 | 2017 | 2246 | 0.090 |
Why?
|
| Risk Factors | 1 | 2023 | 10933 | 0.070 |
Why?
|
| Biomarkers | 1 | 2017 | 3408 | 0.070 |
Why?
|
| Female | 3 | 2025 | 71446 | 0.060 |
Why?
|
| Enterovirus A, Human | 1 | 2023 | 3 | 0.050 |
Why?
|
| Male | 2 | 2021 | 65400 | 0.050 |
Why?
|
| Helper Viruses | 1 | 2023 | 46 | 0.050 |
Why?
|
| Herpesvirus 6, Human | 1 | 2023 | 55 | 0.050 |
Why?
|
| Peritonitis | 1 | 2022 | 77 | 0.050 |
Why?
|
| Ascites | 1 | 2022 | 103 | 0.050 |
Why?
|
| Viremia | 1 | 2022 | 132 | 0.050 |
Why?
|
| Recurrence | 1 | 2025 | 1469 | 0.040 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2023 | 293 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2023 | 510 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2023 | 603 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2023 | 675 | 0.040 |
Why?
|
| Public Health | 1 | 2022 | 284 | 0.040 |
Why?
|
| Inflammation | 1 | 2023 | 1545 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2022 | 14904 | 0.020 |
Why?
|